€25 million investment helps HTBA produce all active forms of B12

€25 million investment helps HTBA produce all active forms of B12

HealthTech BioActives (HTBA) has completed a €25 million investment project to modernise its research, development and manufacturing centre in Murcia, Spain. The initiative included the construction of a new state-of-the-art production plant, which was officially inaugurated on Tuesday 28 January, making HTBA the only company in Europe capable of producing all active forms of vitamin…


HealthTech BioActives (HTBA) has completed a €25 million investment project to modernise its research, development and manufacturing centre in Murcia, Spain.

The initiative included the construction of a new state-of-the-art production plant, which was officially inaugurated on Tuesday 28 January, making HTBA the only company in Europe capable of producing all active forms of vitamin B12, reinforcing its status as a leader in the industry.

The multi-million-euro project aimed to introduce advanced manufacturing processes and sustainability measures to strengthen HTBA’s position as a prominent player in the sector and reduce its environmental footprint.

The investment also involved the modernisation of the company’s existing citrus flavonoid production plant, enabling further development of HTBA’s patented manufacturing process for a specific type of flavonoid, diosmin – an ingredient that can help promote blood circulation and address vascular discomfort. This new production process replaces artificial solvents with water. As a result, HTBA is now the only company in the world capable of manufacturing diosmin without the use of artificial solvents.

“Our origins in citrus flavonoids and vitamin B12 date back more than 45 years and this innovation project marks a huge milestone for HTBA, demonstrating our unwavering dedication to producing high-quality, environmentally responsible products on a global scale,” comments Alexandre Valls-Coma, chief executive officer of HTBA. “Through this significant investment, we’re not only reinforcing our global leadership in the production of active forms of vitamin B12 and citrus flavonoids, but we’re also furthering our commitment to upholding the highest standards in sustainability and innovation.”

In line with the company’s ongoing commitment to sustainability, the new and upgraded facilities harness advanced technology and automation systems that support the use of renewable energy and optimise resource consumption. Overall, the investment has enabled 98% of waste generated to be recovered, revalued or recycled.

Related content


Stories for you


  • Technosys expands Gainsborough site and workforce

    Technosys expands Gainsborough site and workforce

    Technosys is expanding its Gainsborough site and workforce capacity significantly. The Autopack Group business says added factory space will support higher VFFS production, customer line testing, and two new machine models launching later this year.


  • Domino to show integrated coding systems

    Domino to show integrated coding systems

    Domino will demonstrate connected coding systems at interpack in May. The 2026 programme focuses on 2D codes, verification, automation, sustainability, and traceability across food, beverage, life sciences, and secondary packaging.